Literature DB >> 16963751

Genetic and experimental comparison of porcine circovirus type 2 (PCV2) isolates from cases with and without PCV2-associated lesions provides evidence for differences in virulence.

T Opriessnig1, N E McKeown, E-M Zhou, X-J Meng, P G Halbur.   

Abstract

There are marked differences in the clinical expression of diseases associated with porcine circovirus type 2 (PCV2) in the field. The objective of this study was to compare the sequences and pathogenicity of PCV2 isolates from field cases with and without PCV2-associated lesions. Forty-two specific-pathogen-free (SPF) pigs were assigned randomly to three groups of 14 pigs each. At 7 weeks of age, group 1 pigs were mock-inoculated with saline, group 2 pigs were inoculated with PCV2-4838 (isolated from a pig with no evidence of PCV2-associated lymphoid lesions) and group 3 pigs were inoculated with PCV2-40895 (isolated from a pig with PCV2-associated lymphoid lesions and disease). The PCV2-4838 and PCV2-40895 isolates shared approximately 98.9 % nucleotide sequence identity across the entire genome. A total of nine amino acid changes in ORF2 and two amino acid changes in ORF1 were identified between the two isolates. PCV2-4838-inoculated pigs had significantly more genomic copy numbers of PCV2 in their sera at 7 days post-inoculation (p.i.) (P<0.0001) and significantly fewer genomic copy numbers at 14, 21 and 28 days p.i. (P<0.05) compared with pigs inoculated with the PCV2-40895 isolate. Microscopic lesions in lymphoid tissues were significantly less severe (P<0.05) and the amount of PCV2 antigen associated with these lesions was significantly lower (P<0.05) in pigs inoculated with PCV2-4838. The results of this study suggest that PCV2 isolates from the USA differ in virulence in an SPF pig model.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16963751     DOI: 10.1099/vir.0.82099-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  23 in total

1.  Retrospective surveillance of porcine circovirus 4 in pigs in Inner Mongolia, China, from 2016 to 2018.

Authors:  Zhuo Ha; Chengdong Yu; Changzhan Xie; Guanyu Wang; Ying Zhang; Pengfei Hao; Jinfeng Li; Zhuoxin Li; Yanwei Li; Fulong Rong; Fulong Nan; He Zhang; Xinyu Zhuang; Yubiao Xie; Ning Shi; Huijun Lu; Ningyi Jin
Journal:  Arch Virol       Date:  2021-05-13       Impact factor: 2.574

2.  Cellular adaptive immune response against porcine circovirus type 2 in subclinically infected pigs.

Authors:  Esther Steiner; Carole Balmelli; Heidi Gerber; Artur Summerfield; Kenneth McCullough
Journal:  BMC Vet Res       Date:  2009-12-22       Impact factor: 2.741

3.  Genomic analysis of porcine circovirus type-2 isolates in Alberta pigs demonstrating clinical porcine circovirus associated disease (PCVAD).

Authors:  Leila McIntyre; Mark Chaiyakul; Edward G Clark; Frank Marshall; Markus Czub
Journal:  Can J Vet Res       Date:  2010-04       Impact factor: 1.310

4.  Characterization of a new disease syndrome associated with porcine circovirus type 2 in previously vaccinated herds.

Authors:  Ada G Cino-Ozuna; Steven Henry; Richard Hesse; Jerome C Nietfeld; Jianfa Bai; H Morgan Scott; Raymond R R Rowland
Journal:  J Clin Microbiol       Date:  2011-02-23       Impact factor: 5.948

5.  Coreplication of the major genotype group members of porcine circovirus type 2 as a prerequisite to coevolution may explain the variable disease manifestations.

Authors:  Siegfried Khaiseb; Titus Sydler; Dieter Zimmermann; Andreas Pospischil; Xaver Sidler; Enrico Brugnera
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

6.  Phylogenetic analysis of porcine circovirus type 2 (PCV2) pre- and post-epizootic postweaning multisystemic wasting syndrome (PMWS).

Authors:  Sirje Timmusk; Per Wallgren; Inger Marit Brunborg; Frida Hasslung Wikström; Gordon Allan; Brian Meehan; Michael McMenamy; Francis McNeilly; Lisbeth Fuxler; Katinka Belák; Diivi Põdersoo; Tiiu Saar; Mikael Berg; Caroline Fossum
Journal:  Virus Genes       Date:  2008-03-15       Impact factor: 2.332

7.  Insights into the evolutionary history of an emerging livestock pathogen: porcine circovirus 2.

Authors:  Cadhla Firth; Michael A Charleston; Siobain Duffy; Beth Shapiro; Edward C Holmes
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

8.  The emergence of a new strain of porcine circovirus-2 in Ontario and Quebec swine and its association with severe porcine circovirus associated disease--2004-2006.

Authors:  Susy Carman; Hugh Y Cai; Josepha DeLay; Sameh A Youssef; Beverly J McEwen; Carl A Gagnon; Donald Tremblay; Murray Hazlett; Peter Lusis; Jim Fairles; Hazel S Alexander; Tony van Dreumel
Journal:  Can J Vet Res       Date:  2008-04       Impact factor: 1.310

9.  Limited susceptibility of three different mouse (Mus musculus) lines to Porcine circovirus-2 infection and associated lesions.

Authors:  Tanja Opriessnig; Abby R Patterson; Douglas E Jones; Nicole M Juhan; Xiang-Jin Meng; Patrick G Halbur
Journal:  Can J Vet Res       Date:  2009-04       Impact factor: 1.310

10.  Porcine circovirus type 2 (PCV2)-infection and re-inoculation with homologous or heterologous strains: virological, serological, pathological and clinical effects in growing pigs.

Authors:  Tanja Opriessnig; John R Prickett; Darin M Madson; Hui-Gang Shen; Nicole M Juhan; Roman R Pogranichniy; Xiang-Jin Meng; Patrick G Halbur
Journal:  Vet Res       Date:  2010-01-18       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.